Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,256 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,466
Recruiting: 821
Ph III recruiting: 96
Growth YoY: +7.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 751–800 of 6,256 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06390995	A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors	active not recruiting	Phase 1 / Phase 2	28	TakedaINDUSTRY	1	Jun 16, 2026	clinicaltrials
NCT07625943	HYPOfractionated RadioTherapy in Cervical Cancer(HYPORT-CC)	recruiting	N/A	396	All India Institute of Medical SciencesOTHER	1	Jun 16, 2026	clinicaltrials